Prospective, Case-Control Study of Serological Response After Two Doses of BNT162b2 Anti-SARS-CoV-2 MRNA Vaccine in Transfusion-Dependent Thalassemic Patients. Mediterr J Hematol Infect Dis 2022, 14 (1), e2022056. https://doi.org/10.4084/MJHID.2022.056.